Rabeprazole Sodium

CHEMBL1200930 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
381.4 g/mol
LogP
Phase
4

The sodium salt form of rabeprazole used to treat GERD and peptic ulcers by significantly reducing the amount of acid the stomach produces. It is typically taken once daily before a meal for effective acid control.

Moleküler Ağırlık

381,4000 g/mol

TPSA

81,50 Ų

Terapötik Alanlar

Etki Mekanizması

Proton pump inhibitor irreversibly inhibiting gastric H+/K+-ATPase with faster onset than omeprazole.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mekanizma

Proton pump inhibitor irreversibly inhibiting gastric H+/K+-ATPase with faster onset than omeprazole.

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[n-]2)c1C.[Na+]

InChI

InChI=1S/C18H20N3O3S.Na/c1-13-16(19-9-8-17(13)24-11-5-10-23-2)12-25(22)18-20-14-6-3-4-7-15(14)21-18;/h3-4,6-9H,5,10-12H2,1-2H3;/q-1;+1

Molecular Formula

C18H20N3NaO3S

HBD / HBA

- / 7

Döndürülebilir Bağlar

8

Ağır Atomlar

26

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

The sodium salt form of rabeprazole used to treat GERD and peptic ulcers by significantly reducing the amount of acid the stomach produces. It is typically taken once daily before a meal for effective acid control.

Proton pump inhibitor irreversibly inhibiting gastric H+/K+-ATPase with faster onset than omeprazole.

Yes, Rabeprazole Sodium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200930. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 14720269. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.